AERIUS desloratadine 5mg tablet

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ixtrih issa

Ingredjent attiv:

desloratadine, Quantity: 5 mg

Disponibbli minn:

Bayer Australia Ltd

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: Carnauba Wax; white beeswax; microcrystalline cellulose; maize starch; calcium hydrogen phosphate dihydrate; purified talc; hypromellose; macrogol 400; titanium dioxide; lactose monohydrate; indigo carmine

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

2,3,5,7,10,14,15,20,25,28,30,42,45,50,60, 1 tablet (Sample Pack)

Tip ta 'preskrizzjoni:

(S2) Pharmacy Medicine

Indikazzjonijiet terapewtiċi:

The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinits include rhinorrhoea, sneezing and nasal itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate., The relief of symptoms associated with perennial allergic rhinitis., The symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

Sommarju tal-prodott:

Visual Identification: Light blue round embossed film-coated tablets.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2003-05-28